THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
<p>Up to date antithrombotic medications applied in patients with atrial fibrillation are discussed. Along with traditional drugs (acetylsalicylic acid, warfarin) rivaroxaban is specially considered<br />in terms of efficacy and safety of alone.</p>
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Столичная издательская компания
2015-12-01
|
| シリーズ: | Рациональная фармакотерапия в кардиологии |
| 主題: | |
| オンライン･アクセス: | http://www.rpcardio.ru/jour/article/view/504 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|